The diabetic treatments used in the non-metformin group included: sulfonylureas (n = 10), insulin (n = 7), diet control (n = 8), and thiazolidinedione (n = 3), 6 of these subjects changed diabetes treatment before the time of last follow-up, but none changed to metformin. This evidence concerns the gene INS and diabetes mellitus.